Advertisement
Canada markets open in 4 hours 11 minutes

  • S&P/TSX

    22,346.76
    -121.40 (-0.54%)
     

  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     

  • DOW

    39,671.04
    -201.95 (-0.51%)
     

  • CAD/USD

    0.7311
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    77.76
    +0.19 (+0.24%)
     

  • Bitcoin CAD

    95,346.34
    -317.66 (-0.33%)
     

  • CMC Crypto 200

    1,500.46
    -2.21 (-0.15%)
     

  • GOLD FUTURES

    2,363.80
    -29.10 (-1.22%)
     

  • RUSSELL 2000

    2,081.71
    -16.65 (-0.79%)
     

  • 10-Yr Bond

    4.4340
    +0.0200 (+0.45%)
     

  • NASDAQ futures

    18,933.00
    +146.25 (+0.78%)
     

  • VOLATILITY

    11.63
    -0.66 (-5.37%)
     

  • FTSE

    8,362.25
    -8.08 (-0.10%)
     

  • NIKKEI 225

    39,103.22
    +486.12 (+1.26%)
     

  • CAD/EUR

    0.6745
    0.0000 (0.00%)
     

R1 RCM to Release Second Quarter 2023 Results on August 2

R1 RCM Inc.
·1 min read
R1 RCM Inc.
R1 RCM Inc.

MURRAY, Utah, July 12, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2023, before market open on Wednesday, August 2, 2023.

R1’s management team will host a conference call on August 2 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at r1rcm.com.

About R1 RCM
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.

Contact:
R1 RCM Inc.
Investor Relations:
Atif Rahim
312.324.5476
investorrelations@r1rcm.com

Media Relations:
Allison + Partners
Amanda Critelli
R1PR@allisonpr.com